Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J CURIEL

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Cancer Research|December 16, 2014
Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanismSiqi Chen, Long Wang, Jie Fan, et al.
Cancer Research|November 19, 2004
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signalsLinhua Zou, Brian Barnett, Hana Safah, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2007
Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infectionShuang Wei, Benjamin J Daniel, Michael J Brumlik, et al.
International Journal of Biological Sciences|April 1, 2020
PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic mannerBogang Wu, Xiujie Sun, Bin Yuan, et al.
Oncoimmunology|December 3, 2021
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturationRyan M Reyes, Chenghao Zhang, Yilun Deng, et al.
Leukemia Research|July 20, 2002
Establishment and characterization of a new mantle cell lymphoma cell line, MinoR Lai, T J McDonnell, S L O'Connor, et al.
Aging and Cancer|March 6, 2023
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young miceMyrna G Garcia, Yilun Deng, Clare Murray, et al.
Journal for Immunotherapy of Cancer|January 19, 2021
Estrogen receptor beta signaling in CD8<sup>+</sup> T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switchBin Yuan, Curtis A Clark, Bogang Wu, et al.
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Aging Cell|March 1, 2012
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cellsLishi Sun, Vincent J Hurez, Suzanne R Thibodeaux, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Cancer Research|December 16, 2014
Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanismSiqi Chen, Long Wang, Jie Fan, et al.
Cancer Research|November 19, 2004
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signalsLinhua Zou, Brian Barnett, Hana Safah, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2007
Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infectionShuang Wei, Benjamin J Daniel, Michael J Brumlik, et al.
International Journal of Biological Sciences|April 1, 2020
PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic mannerBogang Wu, Xiujie Sun, Bin Yuan, et al.
Oncoimmunology|December 3, 2021
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturationRyan M Reyes, Chenghao Zhang, Yilun Deng, et al.
Leukemia Research|July 20, 2002
Establishment and characterization of a new mantle cell lymphoma cell line, MinoR Lai, T J McDonnell, S L O'Connor, et al.
Aging and Cancer|March 6, 2023
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young miceMyrna G Garcia, Yilun Deng, Clare Murray, et al.
Journal for Immunotherapy of Cancer|January 19, 2021
Estrogen receptor beta signaling in CD8<sup>+</sup> T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switchBin Yuan, Curtis A Clark, Bogang Wu, et al.
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Aging Cell|March 1, 2012
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cellsLishi Sun, Vincent J Hurez, Suzanne R Thibodeaux, et al.
Pageof 15